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COMMENT&RESPONSE
Cost Sharing DoesNot Lead to anOverall Increase
of Involuntary Commitments in theNetherlands
To theEditor In2012, theDutchgovernment increased theout-
of-pocket price formental health care, aiming to achieve cost
savings but possibly overlooking negative downstream con-
sequences. Ravesteijn and colleagues1 showed that immedi-
atelyafter the introductionof thenewcost-sharingpolicy, regu-
lar service use decreased by 13.4%. In contrast, acute mental
health care use increased by 25.1% and involuntary commit-
ment increased by 96.8%. The authors concluded that the
higherout-of-pocketprice generatedaggregate savingsbut in-
creased costs for acute care and involuntary commitment.
However, these numbers donotmatch other information
sources or everyday clinical practice, to our knowledge.
Ravesteijn and colleagues1 reported an absolute doubling of
all court-ordered and emergency involuntary commitments,
from 1092 in 2011 to 2156 in 2012. However, according to data
from the Council for the Judiciary, the increase from 2011 to
2012 was only 3%, whereas the total number of involuntary
outpatient treatment and admissions counted more than
20000.2What canRavesteijn and colleagues1 conclude about
increased costs based on data that compose less than 10% of
all involuntary commitments? Moreover, generally, court-
ordered treatment and involuntary commitment in theNeth-
erlands is not the start of a new care trajectory after a period
withoutmental health care contacts. These commitments are
anultimumremediumissuedmostlyonlyafterprevious treat-
ment efforts have failed.3
Ravesteijn and colleagues1 highlighted that service use
changed right after cost sharing had been increased. How-
ever,manypatientswith serious psychiatric illnesses in long-
term treatment trajectorieswere not immediately affected by
thereform.Out-of-pocketcostswerenotbilled in2012; insome
cases, billing was delayed until 2014. On top of that, several
city councils compensated out-of-pocket treatment costs
through social benefits. More importantly, higher cost shar-
ing did not involve assertive outreach teams, emergency psy-
chiatry, or involuntary commitments. Because billing of out-
of-pocket expenseswasdelayed andhealth care programs for
the most vulnerable populations were spared, the abrupt in-
creaseof acutemental health care records and involuntary ad-
missions seems counterintuitive.
The study by Ravesteijn and colleagues1 is one of the first
to evaluatehealth care reform in theNetherlandsusing thena-
tionaldatabaseof treatment recordsandhealth care costs. The
results beg to ask whether this kind of data reliably reflects
changes in mental health care use. It would be interesting to
investigate what happened after the national government al-
ready abolished the mental health copayments in 2013.
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In ReplyWe thank Wierdsma and Mulder for their comments
on our article,1 which investigated the effects of a 2012 in-
crease in cost sharing for specialist mental health care in the
Netherlands. Our article shows that after the increase in cost
sharing, therewasa sharpdecline in treatment recordsopened
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for regular careandasharp increase in recordsopenedforacute
care and for involuntary commitment (rising from 1092 rec-
ords in 2011 to 2156 in 2012).1
Wierdsma and Mulder point out that in the Netherlands,
the total number of involuntary commitments ismuchhigher
(more than 20000 annually) and that there was a 3% rise in
these total numbers between 2011 and 2012. However, their
figures refer to requested commitments rather than thenum-
ber of commitment requests thatwere grantedandexecuted.2
Moreover,WierdsmaandMulder includecommitments indis-
abilityornursinghomes, those thatoccurduring treatment rec-
ords thathavealreadybeenopenforat least 1month3andthose
that occur during inpatient mental health treatment beyond
a year. In our data, we tested whether, after the cost sharing
increase, some individuals avoided mental health care but
eventually experienced involuntary committments. That is
whyweexclusively investigated thenumberof specialistmen-
tal health care treatment records that were opened for invol-
untary commitment. We would not have been able to study
this effect if involuntary commitment within ongoing treat-
ment records had been included.
Wierdsma and Mulder also argue that the increase in in-
voluntary commitment after the reform seems counterintui-
tive. However, our findings are consistent with 2 mecha-
nisms through which we expected involuntary commitment
to increase. First, a commitment procedure could be initiated
immediatelyafter ithadbecomeclear that an individualwould
either not voluntarily seek treatment or discontinue treat-
ment beyond the maximum duration of a treatment record,
while treatmentwasdeemedcritical for that individual’swell-
being. Second, once individuals forwent treatment after the
reform, theirmental health coulddeteriorate to thepoint that
a commitment procedure was eventually initiated. In our
article,1 we showed a decrease in treatment of patients with
psychosis (–10.6%) and bipolar disorder (–6.5%) and a 16.3%
decrease among the lowest income decile. Therefore, it ap-
pears that themost vulnerable populationswere certainly af-
fected by the reform.
We agree that there are important limitations inherent in
our methods, which we enumerate in the Discussion section
of our article.1 Still, we are convinced that the Dutch reform
offers an excellent opportunity to study the effects of patient
cost sharing for mental health care and that the registries we
accessed for the study are among the best available. More-
over, additional analyses on the full treatment record data set
that was recentlymade available to us confirm our published
findings (unpublished data, 2017).
In conclusion, althoughweappreciateWierdsmaandMul-
der’s comments, the conclusions presented in our article are
sound and suggest that reducing coverage for mental health
care may have negative unintended consequences for pa-
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Tramadol Extended Release andOpioidWithdrawal
Management—Legal Implications
To theEditorThestudy investigating theefficacyof tramadolex-
tendedreleaseforopioidwithdrawalbyDunnetal1offersaprom-
ising approach to themanagement of acute opioidwithdrawal.
SubstanceabusetreatmentprogramsintheUnitedStatesthatpro-
videmanagement of acute opioid withdrawal in inpatient and
residentialsettingscurrentlyusemethadone(ifregisteredasanar-
cotic treatmentprogram),buprenorphine,ornonopioidmedica-
tion (such as clonidine), and the results of the study by Dunn
etal1suggestthattramadolextendedreleasemaybeanadditional
tool in the addiction psychiatrist’s armamentarium for treating
patients inacuteopioidwithdrawal.However,basedonmyun-
derstandingof theUS federaldrug laws, theuseof tramadol ex-
tendedreleasemayonlybepermissible if thetreatmentprogram
is registeredwith theUSDrugEnforcementAdministrationasa
narcotic treatment program. For inpatient and residential sub-
stanceabusetreatmentprogramsnotregisteredwiththeUSDrug
EnforcementAdministrationasanarcotictreatmentprogram,fed-
eral law2stipulates thatonlySchedule III, IV,orVnarcoticmedi-






pears to be forbiddenby this lawunless the treatment program
isregisteredbytheUSDrugEnforcementAdministrationasanar-
cotic treatmentprogram.At thepresent time, there isonly 1opi-
oidmedicationavailable thatmeets the criteria foruse in apro-
gram that is not registered as a narcotic treatment program:
buprenorphine.2Manyaddictiontreatmentcenters intheUnited
States providingopioidwithdrawalmanagement (ie, “detoxifi-
cation”)servicesarenotregisteredwiththeUSDrugEnforcement
Administrationasanarcotic treatmentprogram,and it is impor-
tant thathealthcareprofessionalsareawareof the federal regu-
lationsgoverningtheuseofopioidmedicationsintreatingpatients
with substance use disorders.
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